Deakin University
Browse

Cardiovascular efficacy and safety of bococizumab in high-risk patients

Version 3 2025-04-07, 05:42
Version 2 2024-05-30, 12:28
Version 1 2020-09-21, 15:48
journal contribution
posted on 2025-04-07, 05:42 authored by PM Ridker, J Revkin, P Amarenco, R Brunell, M Curto, F Civeira, M Flather, RJ Glynn, J Gregoire, JW Jukema, Y Karpov, JJP Kastelein, W Koenig, A Lorenzatti, P Manga, U Masiukiewicz, M Miller, A Mosterd, J Murin, JC Nicolau, S Nissen, P Ponikowski, RD Santos, PF Schwartz, H Soran, H White, RS Wright, M Vrablik, C Yunis, CL Shear, JC Tardif, D Conde, D Colquhoun, L Missault, J Grégoire, R Gao, M Urina, M Solar, HK Jensen, D Grobbee, M Savolainen, FN Schiele, G Montalescot, I Edes, G Blake, C Lotan, A Maggioni, S Savonitto, CW Lee, JL Leiva Pons, GA Dan, JB Cortada, L Mellbin, T Kahan, S Noble, JJ Hwang, P Sritara, L Tökgozoğlu, L Tarasenko, JS Borer, H Black, R Carmena, KL Furie, J McMurray, J Neaton, F Zannad, B O’Neill, F Welty, R McNamara, H Chun, JD Abbott, D Jacoby, C McPherson, F Jadbabaie, D Pinto, L McCullough, IE Silverman, LH Sansing, J Dearborn-Tomazos, J Foody, J Schindler, G Piazza, A Chakrabarti, Y Pride, E Gelfand, D Baultrukonis, S Chaudhuri, R Frederich, M Johnson, K Mridha, C Powell, E Wang, C Wei, P Anderson, M Buonanno, C Epsley, B Evans, M Frolova, M Goetsch, D Hessinger, Michael BerkMichael Berk
Cardiovascular efficacy and safety of bococizumab in high-risk patients

History

Journal

New England journal of medicine

Volume

376

Pagination

1527-1539

Location

Boston, Mass.

ISSN

0028-4793

eISSN

1533-4406

Language

eng

Publication classification

C1 Refereed article in a scholarly journal

Issue

16

Publisher

Massachusetts Medical Society

Usage metrics

    Research Publications

    Categories

    No categories selected

    Exports

    RefWorks
    BibTeX
    Ref. manager
    Endnote
    DataCite
    NLM
    DC